中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 41 Issue 11
Nov.  2025
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2025  >  41(11): 2343-2350

Distribution of traditional Chinese medicine syndromes in intrahepatic cholestasis of pregnancy and its association with perinatal outcomes

DOI: 10.12449/JCH251122

  • Department of Obstetrics，The Affiliated Hospital of Chengdu University of Traditional Chinese Medicine，Chengdu 610075，China

Research funding:

Special Research Project of Traditional Chinese Medicine, Sichuan Provincial Administration of Traditional Chinese Medicine, 2023 (2023MS012)

More Information
  • Corresponding author: WANG Xiaoyin， 1303@cdutcm.edu.cn （ORCID： 0009-0009-8259-794X）
  • Received Date: 2025-06-11
  • Accepted Date: 2025-07-09
  • Published Date: 2025-11-25
    Abstract
  •   Objective  To investigate the distribution of traditional Chinese medicine （TCM） syndromes in intrahepatic cholestasis of pregnancy （ICP） and its association with perinatal outcomes， and to provide a basis for precise treatment based on TCM syndrome differentiation.  Methods  A cross-sectional study was conducted among 275 patients with ICP who were admitted to The Affiliated Hospital of Chengdu University of Traditional Chinese Medicine from April 2023 to April 2025. A hierarchical cluster analysis was used to summarize TCM syndromes. The Kruskal-Wallis H test was used for comparison of non-normally distributed continuous data between groups， and the chi-square test was used for comparison of categorical data between groups. A multivariate Logistic regression analysis was used to identify the clinical features significantly associated with TCM syndrome.  Results  The cluster analysis identified three core TCM syndromes among the 275 patients with ICP， i.e.， liver-gallbladder damp-heat syndrome （45.8%）， syndrome of blood deficiency generating wind （30.9%）， and liver depression and spleen deficiency syndrome （23.3%）. There was a significant difference in the distribution of TCM syndromes between different groups stratified by maternal age at delivery， parity， history of ICP recurrence， gestational weeks at disease onset， total bile acid （TBA）， alanine aminotransferase （ALT）， and comorbidity with gestational diabetes mellitus （GDM） （all P<0.05）. The multivariate Logistic regression analysis showed that<34 gestational weeks at disease onset was significantly associated with all three syndromes （damp-heat： odds ratio ［OR］=3.769， P<0.001； blood deficiency： OR=4.031， P<0.001； liver stagnation： OR=3.552， P<0.001）. Liver-gallbladder damp-heat syndrome was associated with maternal age ≥35 years at disease onset （OR=2.048， P=0.014）， parity ≥2 times （OR=1.921， P=0.034）， history of ICP recurrence （OR=2.404， P=0.030）， ALT ≥200 U/L （OR=2.051， P=0.018）， comorbidity with GDM （OR=1.944， P=0.029）， and TBA ≥40 μmol/L （OR=2.542， P=0.024）. The syndrome of blood deficiency generating wind syndrome was associated with maternal age ≥35 years （OR=2.939， P=0.003）， parity ≥2 time （OR=3.222， P=0.003）， history of ICP recurrence （OR=3.809， P=0.010）， ALT ≥200 U/L （OR=2.889， P=0.006）， comorbidity with GDM （OR=3.711， P=0.001）， and comorbidity with hypertensive disorders of pregnancy （OR=4.472， P=0.011）. Liver depression and spleen deficiency syndrome was associated with TBA ≥40 μmol/L （OR=2.995， P=0.044）. The analysis of perinatal outcomes showed that there were significant differences in mode of delivery， gestational weeks at the time of delivery， postpartum blood loss， and neonatal birth weight between the three groups with different TCM syndromes （all P<0.05）.  Conclusion  Liver-gallbladder damp-heat syndrome， syndrome of blood deficiency generating wind， and liver depression and spleen deficiency syndrome are the main TCM syndrome types in ICP， and the distribution of TCM syndromes is closely associated with clinical factors and perinatal outcomes， which provides a basis for precise TCM syndrome differentiation and individualized treatment.

     

    • FullText(HTML)
  • loading
    • References(17)
  • [1]
    HOBSON SR, COHEN ER, GANDHI S, et al. Guideline No. 452: Diagnosis and management of intrahepatic cholestasis of pregnancy[J]. J Obstet Gynaecol Can, 2024, 46( 8): 102618. DOI: 10.1016/j.jogc.2024.102618.
    [2]
    LI YJ, LIU HY, HAN WH, et al. Incidence and characteristics of intrahepatic cholestasis of pregnancy in 4081 hospitalized pregnant women[J]. Fudan Univ J Med Sci, 2018, 45( 4): 490- 495. DOI: 10.3969/j.issn.1672-8467.2018.04.009.

    李意杰, 刘海燕, 韩文晖, 等. 4081例住院孕妇妊娠期肝内胆汁淤积症发病率及分布特征[J]. 复旦学报(医学版), 2018, 45( 4): 490- 495. DOI: 10.3969/j.issn.1672-8467.2018.04.009.
    [3]
    LIU YH, WEI YD, CHEN XH, et al. Genetic study of intrahepatic cholestasis of pregnancy in Chinese women unveils East Asian etiology linked to historic HBV epidemic[J]. J Hepatol, 2025, 82( 5): 826- 835. DOI: 10.1016/j.jhep.2024.11.008.
    [4]
    Obstetrics Group of Society of Obstetrics and Gynecology, Chinese Medical Association; Perinatal Medicine Society, Chinese Medical Association. Guidelines for clinical diagnosis, treatment and management of intrahepatic cholestasis of pregnancy(2024)[J]. Chin J Obstet Gynecol, 2024, 59( 2): 97- 107. DOI: 10.3760/cma.j.cn112141-20230914-00099.

    中华医学会妇产科学分会产科学组, 中华医学会围产医学分会. 妊娠期肝内胆汁淤积症临床诊治和管理指南(2024版)[J]. 中华妇产科杂志, 2024, 59( 2): 97- 107. DOI: 10.3760/cma.j.cn112141-20230914-00099.
    [5]
    LIN X, WU XO, ZHENG Z, et al. Clinical observation of Yinhuang Lidan Huoxue particles combined ursodeoxycholic acid in treatment of mild intrahepatic cholestasis of pregnancy patients with hepatobiliary dampness-heat syndrome[J]. Chin J Integr Tradit West Med, 2021, 41( 8): 912- 916. DOI: 10.7661/j.cjim.20210518.172.

    林希, 吴晓鸥, 郑智, 等. 茵黄利胆活血颗粒联合熊去氧胆酸治疗轻度妊娠肝内胆汁淤积症肝胆湿热型的临床观察[J]. 中国中西医结合杂志, 2021, 41( 8): 912- 916. DOI: 10.7661/j.cjim.20210518.172.
    [6]
    LU JN, JIAO B, WU QP, et al. Effect of western medicine combined with Yinzhihuang on postpartum hemorrhage and pregnancy outcome of intrahepatic cholestasis of pregnancy: A meta-analysis[J]. Pharmacol Clin Chin Mater Med, 2024, 40( 8): 76- 81. DOI: 10.13412/j.cnki.zyyl.20240814.002.

    卢佳南, 焦波, 吴俏坪, 等. 西药联合茵栀黄对妊娠肝内胆汁淤积症产后出血量及妊娠结局影响的Meta分析[J]. 中药药理与临床, 2024, 40( 8): 76- 81. DOI: 10.13412/j.cnki.zyyl.20240814.002.
    [7]
    Obstetrics Subgroup, Society of Obstetrics and Gynecology, Chinese Medical Association. Guidelines for the management of intrahepatic cholestasis of pregnancy(2015)[J]. J Clin Hepatol, 2015, 31( 10): 1575- 1578. DOI: 10.3969/j.issn.1001-5256.2015.10.003.

    中华医学会妇产科学分会产科学组. 妊娠期肝内胆汁淤积症诊疗指南(2015)[J]. 临床肝胆病杂志, 2015, 31( 10): 1575- 1578. DOI: 10.3969/j.issn.1001-5256.2015.10.003.
    [8]
    ZHENG XY. Guiding principles for clinical research of new Chinese medicine: Trial implementation[M]. Beijing: China Medical Science Press, 2002.

    郑筱萸. 中药新药临床研究指导原则: 试行[M]. 北京: 中国医药科技出版社, 2002.
    [9]
    State Administration for Market Regulation, Standardization Administration of China. Clinical terminology of Traditional Chinese Medicine—Part 2: Syndromes: GB/T 16751.2-2021[S]. Beijing: Standards Press of China, 2021.

    国家市场监督管理总局, 国家标准化管理委员会. 中国临床诊疗术语第2部分:证候: GB/T 16751.2-2021[S]. 北京: 中国标准出版社, 2021.
    [10]
    DU HL. Integrated traditional Chinese and western medicine obstetrics and gynecology[M]. 4th ed. Beijing: China Press of Traditional Chinese Medicine, 2021: 235- 239.

    杜惠兰. 中西医结合妇产科学[M]. 4版. 北京: 中国中医药出版社, 2021: 235- 239.
    [11]
    XIE X, KONG BH, DUAN T. Obstetrics and gynecology[M]. 9th ed. Beijing: People’s Medical Publishing House, 2018: 92- 94.

    谢幸, 孔北华, 段涛. 妇产科学[M]. 9版. 北京: 人民卫生出版社, 2018: 92- 94.
    [12]
    WANG P. Mining the medication rules and syndrome type distribution of intrahepatic cholestasis of pregnancy based on traditional Chinese medicine inheritance assistant platform[D]. Changsha: Hunan University of Chinese Medicine, 2022.

    王普. 基于中医传承辅助平台挖掘妊娠期肝内胆汁淤积症的用药规律及证型分布[D]. 长沙: 湖南中医药大学, 2022.
    [13]
    FANG LH, ZHANG JQ, TANG XD. Modern research progress in diagnosis and treatment of damp-heat syndrome[J]. China J Tradit Chin Med Pharm, 2024, 39( 9): 4793- 4798.

    方俐晖, 张佳琪, 唐旭东. 湿热证诊疗的现代研究进展[J]. 中华中医药杂志, 2024, 39( 9): 4793- 4798.
    [14]
    GAO XX, YE MY, LIU Y, et al. Prevalence and risk factors of intrahepatic cholestasis of pregnancy in a Chinese population[J]. Sci Rep, 2020, 10( 1): 16307. DOI: 10.1038/s41598-020-73378-5.
    [15]
    İPEK G, TANAÇAN A, PEKER A, et al. Systemic Inflammation Response Index as a diagnostic and prognostic predictor of intrahepatic cholestasis of pregnancy: A case-control study from a tertiary center[J]. Int J Gynecol Obstet, 2024, 165( 2): 717- 722. DOI: 10.1002/ijgo.15216.
    [16]
    WU YQ, ZHANG AQ, WAN JY, et al. Mechanism of liver-spleen disharmony in inducing metabolic diseases in phlegm-dampness constitution from the perspective of bile acid metabolism[J]. World Chin Med, 2024, 19( 15): 2303- 2307. DOI: 10.3969/j.issn.1673-7202.2024.15.015.

    吴玉琦, 张安琪, 万瑾毅, 等. 从胆汁酸代谢阐释肝脾失调在痰湿体质易发代谢紊乱中的作用机制[J]. 世界中医药, 2024, 19( 15): 2303- 2307. DOI: 10.3969/j.issn.1673-7202.2024.15.015.
    [17]
    GUO LP, LIU M, JI X, et al. Research progress on treatment of hypertensive disorder complicating pregnancy with traditional Chinese medicine[J]. J Emerg Tradit Chin Med, 2022, 31( 1): 181- 184. DOI: 10.3969/j.issn.1004-745X.2022.01.049.

    郭丽萍, 刘梅, 纪晓, 等. 中医药治疗妊娠期高血压疾病研究进展[J]. 中国中医急症, 2022, 31( 1): 181- 184. DOI: 10.3969/j.issn.1004-745X.2022.01.049.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(7)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (7) PDF downloads(3) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return